Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent (DECLARELONG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00589927
Recruitment Status : Completed
First Posted : January 10, 2008
Last Update Posted : March 18, 2010
Otsuka Korea
Information provided by:
CardioVascular Research Foundation, Korea